- Home
- Publications
- Publication Search
- Publication Details
Title
Antisense oligonucleotides for neurodegeneration
Authors
Keywords
-
Journal
SCIENCE
Volume 367, Issue 6485, Pages 1428-1429
Publisher
American Association for the Advancement of Science (AAAS)
Online
2020-03-27
DOI
10.1126/science.aba4624
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Huntingtin Lowering Strategies for Disease Modification in Huntington’s Disease
- (2019) Sarah J. Tabrizi et al. NEURON
- Targeting Huntingtin Expression in Patients with Huntington’s Disease
- (2019) Sarah J. Tabrizi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent advances in molecular therapies for neurological disease: triplet repeat disorders
- (2019) Pedro Gonzalez-Alegre HUMAN MOLECULAR GENETICS
- Huntingtin suppression restores cognitive function in a mouse model of Huntington’s disease
- (2018) Amber L. Southwell et al. Science Translational Medicine
- Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
- (2017) Lindsay A. Becker et al. NATURE
- Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides
- (2017) Naoki Iwamoto et al. NATURE BIOTECHNOLOGY
- Antisense oligonucleotides: the next frontier for treatment of neurological disorders
- (2017) Carlo Rinaldi et al. Nature Reviews Neurology
- LRRK2 Antisense Oligonucleotides Ameliorate α-Synuclein Inclusion Formation in a Parkinson’s Disease Mouse Model
- (2017) Hien Tran Zhao et al. Molecular Therapy-Nucleic Acids
- Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs
- (2016) Jie Jiang et al. NEURON
- Huntington disease
- (2015) Gillian P. Bates et al. Nature Reviews Disease Primers
- Allele-Specific Suppression of Mutant Huntingtin Using Antisense Oligonucleotides: Providing a Therapeutic Option for All Huntington Disease Patients
- (2014) Niels H. Skotte et al. PLoS One
- Antisense Reduction of Tau in Adult Mice Protects against Seizures
- (2013) S. L. DeVos et al. JOURNAL OF NEUROSCIENCE
- An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study
- (2013) Timothy M Miller et al. LANCET NEUROLOGY
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
- (2012) Holly B. Kordasiewicz et al. NEURON
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started